2008
DOI: 10.1186/1752-1947-2-313
|View full text |Cite
|
Sign up to set email alerts
|

Oral cavity metastasis of renal cell carcinoma: A case report

Abstract: Introduction: Despite being reported rarely, renal cell carcinoma is the third most frequent neoplasm to metastasize to the head and neck region preceded only by breast and lung cancer. Little information exists regarding the presentation and work-up of metastatic renal cell carcinoma in the oral cavity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
42
0
3

Year Published

2009
2009
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(46 citation statements)
references
References 9 publications
1
42
0
3
Order By: Relevance
“…However the patient's treatment was changed to targeted therapy with sunitinib and sorafenib because of progressive disease. Will et al reported that most patients die within 1 year after the detection of head and neck metastasis [18]. Campbell et al reported the overall 5-and 10-year survival rates of patients with metastatic RCC are 5-30% and 0-5%, respectively [19].…”
Section: Discussionmentioning
confidence: 99%
“…However the patient's treatment was changed to targeted therapy with sunitinib and sorafenib because of progressive disease. Will et al reported that most patients die within 1 year after the detection of head and neck metastasis [18]. Campbell et al reported the overall 5-and 10-year survival rates of patients with metastatic RCC are 5-30% and 0-5%, respectively [19].…”
Section: Discussionmentioning
confidence: 99%
“…12 It has been mentioned in the literature that the common site of metastatic renal cell carcinoma in the oral cavity is tongue. Possible routes of metastatic spread to the tongue include lymphatic, arterial and venous spread.…”
Section: Discussionmentioning
confidence: 99%
“…Bu lezyonlar, ana tümör olan RHK gibi radyoterapi ve kemoterapiye dirençlidir. Ancak uygulanan lokal radyoterapi, semptomlarda kısa süreli rahatlama sağlayabilir (13). Metastatik RHK olgularında kullanılan hedefe yönelik immunoterapötik ajanlar, bu olgularda kullanılsa da sağ kalıma katkısı azdır.…”
Section: Olgu Sunumuunclassified